Showing results (1581-1590 of 2,276) with videos related to
Sort By:
Pageof 228
The Journal of Clinical Investigation|November 15, 2022
mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infectionSatomi Ando, Charles M Perkins, Yamato Sajiki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerRafael G Amado, Michael Wolf, Marc Peeters, et al.NPJ Breast Cancer|May 14, 2026
AI-powered and manual assessment of tumor-infiltrating lymphocytes in early HER2-positive breast cancer in NSABP B-41Ilana Schlam, Gong Tang, Khalid AbdulJabbar, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2011
The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivoAlison M Paterson, Keturah E Brown, Mary E Keir, et al.Journal of Leukocyte Biology|November 25, 2010
Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10Marta Rodríguez-García, Filippos Porichis, Olivier G de Jong, et al.The Journal of Biological Chemistry|August 15, 2006
Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domainKieran T Mellody, Lyle J Freeman, Clair Baldock, et al.Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Acute biomarkers of consciousness are associated with recovery after severe traumatic brain injuryYelena G Bodien, Matteo Fecchio, Natalie Gilmore, et al.Gastroenterology|March 21, 2012
Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humansMohanraj Manangeeswaran, Jérôme Jacques, Cecilia Tami, et al.The Journal of Infectious Diseases|August 21, 2004
Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug useAnthony J Freeman, Rosemary A Ffrench, Jeffrey J Post, et al.Nature Immunology|March 29, 2005
TIM-1 induces T cell activation and inhibits the development of peripheral toleranceSarah E Umetsu, Wan-Ling Lee, Jennifer J McIntire, et al.Pageof 228